Arabic Arabic English English French French German German
dark

Hoth Therapeutics Announces Positive Confirmatory Results from In Vivo Model of HT-003 Assets as Potential Treatment Against Acne

Hoth Therapeutics, Inc. announced today that its HT-003 group of assets has yielded positive results in an in vivo acne therapeutic model. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Over 486,000 Prescriptions Dispensed through ‘Wasfaty’ Service in Al-Ahsa

Next Post

Relief Therapeutics Reports that Collaboration Partner, NRx Pharmaceuticals, and Quantum Leap Announce Treatment of Severely Ill COVID-19 Patients with Aviptadil in the I-SPY COVID Trial

Related Posts
Total
0
Share